Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia
Clinical trial NCT06497036 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06497036
- Sponsor
- Geropharm
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-04
- Primary completion
- 2028-03-31
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.